Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA concerns will delay Ariza marketing

April 15, 2002

GW expands phase III program for cannabis-based medicines

April 15, 2002

Enrollment completed in phase II/III trial of Neurodex for emotional lability

April 15, 2002

Preparation and use of NK1 receptor antagonists reported by Roche

April 12, 2002

New Agouron compounds and methods for treating beta-amyloid-mediated conditions

April 12, 2002

GABA-A receptor ligands specifically claimed for cognition disorders in recent patent

April 12, 2002

Study confirms equivalent efficacy for MT-100 and Imitrex in treatment of migraine

April 12, 2002

First patients enrolled in SAIK-MS phase II trial in multiple sclerosis

April 12, 2002

Approvable letter issued for Xyrem in cataplexy

April 12, 2002

E.U. approval for Dynastat in postoperative pain

April 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...